Latest Annual General Meeting News

Prominence Energy reports steady progress in its uranium and gas exploration projects while pursuing new growth opportunities focused on capital efficiency and operational flexibility.

ASF Group Limited reported a $1.58 million cash balance for the December 2024 quarter, highlighting ongoing investments and a director retirement that could influence its strategic direction.

Lake Resources NL reported a robust cash position of AUD 22.56 million for Q4 2024, bolstered by a $13.6 million sale of non-core assets and steady progress on the Kachi lithium project’s environmental and engineering milestones.

Black Dragon Gold's rezoning application for its flagship Salave Gold Project was rejected by local authorities, posing challenges for mining development. Meanwhile, the company secured a strategic placement raising AUD$712,000 to support ongoing operations.

Carawine Resources releases an amended December 2024 quarterly report highlighting exploration progress in the Paterson province and ongoing legal proceedings over a compulsory acquisition by major shareholder QGold.

Vital Metals reports a substantial 56% increase in Measured and Indicated Resources at its Tardiff project, alongside a significant expansion of its Nechalacho land footprint and plans for a forthcoming Scoping Study.

Citigold Corporation reports steady progress in restarting its Charters Towers Gold Project, highlighting successful test mining and ongoing exploration while preparing for large-scale production.

Element 25 Limited has successfully raised AU$2.85 million through an at-the-market share placement with Acuity Capital, issuing 8.7 million shares at a premium price to bolster its working capital.

Karoon Energy plans to expand its on-market share buyback program by an additional US$75 million, aiming to invest a total of US$125 million in shares by the end of 2025 amid a belief that its stock is undervalued.

MRG Metals reports significant progress in its Mozambique Heavy Mineral Sands joint venture with Sinowin Lithium, alongside promising rare earth element exploration results in Zimbabwe, positioning the company for potential growth in strategic mineral markets.

Tivan Limited has advanced its Speewah Fluorite Project with a $7.4 million government grant and Major Project Status, alongside a joint venture MoU with Sumitomo Corporation and promising drilling results at Sandover.

NeuroScientific Biopharmaceuticals has initiated critical IND-enabling studies for its glaucoma drug candidate EmtinB, backed by a solid cash position of A$4.5 million as of December 2024. Preliminary melanin binding results are shaping the path toward first-in-human trials.